Blood and tissue eosinophilia, mistletoe lectin antibodies and quality of life in a breast cancer patient undergoing intratumoral and subcutaneous mistletoe injection;Blut- und gewebseosinophilie, mistellektin-antikörper und lebensqualität bei einer mammakarzinom-patientin unter intratumoraler und subkutaner misteltherapie

Forschende Komplementarmedizin und Klassische Naturheilkunde

Volumn 9, Issue 3, 2002, Pages 160-167

  Kroz M ^a   Schad, F ^a   Matthes, B ^a   Pickartz, H ^b   Girke, M ^a  

^a Gemeinschaftskrankenhaus Havelhohe   (Germany)

^b Institut für Pathologie am Ev Waldkrankenhaus   (Germany)

Author keywords

Breast cancer; Eosinophilia; Mistletoe therapy; Quality of life (QoL); Tumor associated tissue eosinophilia (TATE)

Indexed keywords

ABNOVAVISCUM; ANTINEOPLASTIC AGENT; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; LETROZOLE; PAMIDRONIC ACID; VISCUM ALBUM LECTIN; PLANT MEDICINAL PRODUCT; RIBOSOME INACTIVATING PROTEIN, VISCUM; TOXIN; VEGETABLE PROTEIN;

AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD; BONE METASTASIS; BREAST CARCINOMA; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER THERAPY; CASE REPORT; DRUG EFFICACY; DRUG MEGADOSE; EOSINOPHILIA; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; PLEURA EFFUSION; PNEUMONIA; QUALITY OF LIFE; SEPSIS; STROKE; TISSUE; TREATMENT OUTCOME; WEIGHT GAIN; BONE TUMOR; BREAST TUMOR; DOSE RESPONSE; FATALITY; IMMUNOLOGY; INTRALESIONAL DRUG ADMINISTRATION; METASTASIS; PALLIATIVE THERAPY; PATHOLOGY; PHYTOTHERAPY; SUBCUTANEOUS DRUG ADMINISTRATION; VISCUM ALBUM;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE NEOPLASMS; BREAST NEOPLASMS; CASE REPORT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENGLISH ABSTRACT; EOSINOPHILIA; FATAL OUTCOME; FEMALE; HUMAN; INJECTIONS, INTRALESIONAL; INJECTIONS, SUBCUTANEOUS; MISTLETOE; PALLIATIVE CARE; PHYTOTHERAPY; PLANT PREPARATIONS; QUALITY OF LIFE; TOXINS; TREATMENT OUTCOME; HUMANS; PLANT PROTEINS; TOXINS, BIOLOGICAL;

EID: 2242472029     PISSN: 14247364     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064266     Document Type: Article

References (39)

1. Klinische studien zur misteltherapie karzinomatöser Erkrankungen - Eine übersicht
2. Mistletoe for cancer?
3. Effect of Viscum album in the inhibition of lung metastasis in mice induced by B16F10 melanoma cells
4. Direct cytotoxic effects of preparations used as unconventional methods in cancer therapy in human tumor xenografts in the clonogenic assay and in nude mice
5. Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats
6. Stimulation of the specific immune system by mistletoe extracts
7. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: Prospective nonrandomized and randomized matched-pair studies nested within a cohort study
8. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: A randomised controlled clinical trial
9. Veränderungen der zahl peripherer blutzellen während einer neubegonnenen misteltherapie bei patientinnen mit operiertem mammakarzinom
10. In vitro antitumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5
11. Anti-mistellektin-1-anti-körper (Anti-ML-1-Ak) während der viscumtherapie
12. Does mistletoe therapy influence the defense against epithelial tumors? A critical immunologic analysis
13. Entwicklung eines fragebogens zur lebensqualität auf der grundlage des anthroposophischen menschenbildes
14. Changes in quality of life during acute inpatient naturopathic treatment - Results of the Blankenstein model
15. Komplette remission eines mundhöhlenkarzinoms nach alleiniger mistelbehandlung
16. Intratumorale mistelapplikation bei stenosierendem rezidiv eines cardia-carcioms
17. Maligner pleuraerguß bei verdacht auf bronchial-carcinom, komplette remission
18. Hormonabhängigkeit der brustdrüse und hormontherapie
19. Components of the IGF system mediate the opposing effects of tamoxifen on endometrial and breast cancer cell growth
20. Bisphosphonates and the prevention of metastasis: First evidences from preclinical and clinical studies
21. Antitumour effects of bisphosphonates: First evidence and possible mechanisms
22. Kontrollparameter während der viscumtherapie
23. Intraläsionale und kombinierte subkutan-intravenöse misteltherapie bei einem patienten mit kolonkarzinom
24. Tumour-associated eosinophilia: A review
25. Peripherial lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer
26. The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer
27. Eosinophil infiltration of colonic carcinomas as a prognostic indicator
28. Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx
29. The importance of the eosinophil in head and neck cancer
30. Effect of tumour associated tissue eosinophilia on survival of women with stage IB carcinoma of the uterine cervix
31. Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response
32. Selective peripherial blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report)
33. Cellular localization of interleukin-5 expression in rectal carcinoma with eosinophilia
34. Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients
35. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins
36. Stimulation of antitumour immunity by intrapleural instillation of a Viscum album L. extract
37. Zur therapie des malignen pleuraergusses mit einem mistelpräparat
38. Mammakarzinom der frau